Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes

NCT01226966 · Completed

Last updated 2026-05-28

This study observes how well and safely the diabetes medication liraglutide works in adults with type 2 diabetes by tracking how many participants maintain healthy blood sugar levels over time.

Status Completed The study has finished.

Type Observational

Participants 3,152 people

Who can join Ages 18+ · all sexes

Timeline Started 2010-09 · est. completion 2013-11

Where 1 site · France

What this study is testing ClinicalTrials.gov NCT01226966 ↗

Description as written by the study sponsor.

This observational study is conducted in Europe. The aim of this non-interventional (observational) study is to evaluate the efficacy of liraglutide (Victoza®) and to assess the conditions of use of Victoza® in daily medical practice in France.

Treatments tested

liraglutide Drug

Prescription is done at the discretion of the prescribing physician as part of normal clinical routine.

Main thing measured	Percentage of patients still in liraglutide treatment and having a HbA1c (glycosylated haemoglobin) value below 7.0%
Sponsor	Novo Nordisk A/S
Conditions studied	Diabetes, Diabetes Mellitus, Type 2
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01226966 ↗